Fundraising Fox
Oncimmune
Dortmund, DE · Founded 2006 · 33 employees on LinkedIn · 2 known investors
Find your way into Oncimmune
Sign up to see every warm intro you have to Oncimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.
Founders & leadership
MG
Martin GouldstoneStrategic AdvisorMartin Gouldstone is a biotech executive and board chair. He currently chairs ValiRx, a publicly listed biotech company, and NCIMB, a microbial research organization, while serving as strategic advisor to Alden Scientific.
PB
Petra BuddeChief Scientific OfficerShe has expertise in biomarker discovery and validation, protein array technologies, and autoantibody assays, with a focus on autoimmune diseases and cancer immunotherapy applications.
HZ
Hans-Dieter ZuchtChief Technical OfficerWith 25+ years in biomarker research and operations, he has authored over 50 scientific publications and contributed to EU-funded research in areas including proteomics, bioinformatics, and translational medicine.
JH
James HeywoodCEO, Alden Scientific
EM
Eva Maria JanerusPresident, Alden Scientific
Investors · 2
Founder mafia
2 people who came through Oncimmune went on to found or lead other companies.
Frequently asked questions
- What does Oncimmune do?
- Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.
- Who are Oncimmune's investors?
- Oncimmune's investors include Balderton Capital, Seneca Partners.
- Where is Oncimmune headquartered?
- Oncimmune is headquartered in Dortmund, DE.